What is Nutrisense?
Nutrisense operates at the intersection of wearable technology and preventative medicine. The company provides a comprehensive metabolic health platform that integrates CGM sensors with data-driven insights, allowing users to monitor the real-time impact of diet, exercise, sleep, and lifestyle choices on blood glucose levels. By combining hardware-based biometric tracking with professional guidance from registered dietitians, Nutrisense offers a high-touch accountability model that addresses the growing consumer demand for data-backed wellness solutions. This approach effectively bridges the gap between clinical-grade diagnostics and consumer-facing health optimization, establishing a defensible market position in the rapidly expanding digital therapeutics landscape.
How much funding has Nutrisense raised?
Nutrisense has raised a total of $25.1M across 2 funding rounds:
Debt
$73K
Series A
$25M
Debt (2021): $73K with participation from PPP
Series A (2022): $25M led by 1315 Capital
Key Investors in Nutrisense
1315 Capital
1315 Capital is a healthcare-focused investment firm that specializes in commercial-stage healthcare companies, including healthcare services, pharma/medtech products, outsourcing, and health & wellness.
PPP
Public-Private Partnership
What's next for Nutrisense?
With the recent influx of capital, Nutrisense is well-positioned to accelerate its operational scaling and product development roadmap. The company is expected to focus on enhancing its proprietary data analytics engine, which translates complex glucose telemetry into actionable lifestyle recommendations. Furthermore, the strategic backing provides the necessary resources to expand its market reach, potentially targeting broader enterprise wellness partnerships and deepening its integration with existing health-tech ecosystems. As the company matures, the focus will likely shift toward long-term clinical validation and the expansion of its dietitian-led support infrastructure to maintain high user engagement and retention rates in an increasingly competitive metabolic health market.
See full Nutrisense company page